SMTL ID : 4mxu.1

Human brain aspartoacylase mutant K213E complex with intermediate analog (N-phosphonomethyl-L-aspartate)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

homo-dimer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.21, E.24, R.63, H.116 Ligands: AS9.2 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.21, A:E.24, A:E.24, A:H.116 ZN.3: 4 residues within 4Å: Chain B: H.21, E.24, H.116 Ligands: AS9.4 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:H.21, B:E.24, B:E.24, B:H.116

2 x AS9: N-[HYDROXY(METHYL)PHOSPHORYL]-L-ASPARTIC ACID(Non-covalent)

AS9.2: 14 residues within 4Å: Chain A: H.21, E.24, R.63, N.70, R.71, H.116, N.117, Y.164, R.168, E.178, F.282, E.285, Y.288 Ligands: ZN.1 16 PLIP interactions: 16 interactions with chain A Hydrogen bonds: A:E.24, A:R.63, A:R.63, A:N.70, A:N.117, A:Y.164, A:Y.164, A:E.178, A:Y.288, A:Y.288 Salt bridges: A:H.21, A:R.63, A:R.71, A:H.116, A:H.116, A:R.168 AS9.4: 14 residues within 4Å: Chain B: H.21, E.24, R.63, N.70, R.71, H.116, N.117, Y.164, R.168, E.178, F.282, E.285, Y.288 Ligands: ZN.3 13 PLIP interactions: 13 interactions with chain B Hydrogen bonds: B:R.63, B:R.63, B:N.70, B:N.117, B:Y.164, B:Y.288, B:Y.288 Salt bridges: B:H.21, B:R.63, B:R.71, B:H.116, B:R.168, B:K.291

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wijayasinghe, Y.S. et al., Aspartoacylase catalytic deficiency as the cause of canavan disease: a structural perspective. Biochemistry (2014)

Release Date

2014-07-30

Peptides

Aspartoacylase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Aspartoacylase